Developer docs
API playgroundTry for free, no card

Search company profiles

Nested Knowledge

Full company profile

uuid0002kp1

Namestring
Nested Knowledge
Legal namestring
Nested Knowledge, Inc.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Nested Knowledge, Inc. is a Delaware-incorporated, privately held software company founded in 2018 and headquartered in St. Paul, Minnesota. The company provides a two-part cloud-based evidence synthesis platform composed of AutoLit® — covering the systematic review workflow of literature search, AI-assisted screening, structured data extraction, and critical appraisal — and Synthesis, which delivers qualitative concept summarization, no-code quantitative meta-analysis, shareable dashboards, and living manuscript drafting with auto-updating tables and figures. The platform is designed to serve academic medical researchers, evidence synthesis consultancies, medical device and HEOR specialists, and increasingly biopharma and healthcare media organizations. The company is led by co-founder and CEO Kevin Kallmes, with Karl Holub as CTO and Keith Kallmes as President.

The business model combines a freemium self-serve layer with enterprise subscriptions and embedded professional services. Individual researchers can complete an entire systematic review project for free with no time limits and no credit card required, creating a product-led growth top-of-funnel; enterprise teams are onboarded through tailored pilot projects that include complimentary research support, with annual contract pricing available on request. The company's stated customer base includes HEOR and evidence synthesis firms (ECRI, ICER, FIECON, HEOR Ltd, NAMSA, OPEN Health, RTI Health Solutions, Medlior, Red Nucleus, Decisive Consulting, Indence Health, Marksman Healthcare, Mednavigate, Synex), medical device consultancies (Sterling Medical Devices, Superior Medical Experts, Zoll Medical), and academic institutions (Stanford Neurosurgery, Health Sciences Library), and the company claims to be trusted by thousands of researchers worldwide.

The company is venture-backed, having raised approximately $5.98 million cumulatively across disclosed rounds, including a $4.3 million exempt offering filed in January 2026 (with TCA Venture Group disclosed) and a prior $1.5 million round from Groove Capital in June 2021. Its go-to-market is supported by strategic partnerships announced in late 2025 and early 2026 with Prezent Vivo (biopharma competitive intelligence), Cliniphai (HTA dossier localization), and Pharmacy Podcast Network (healthcare podcasting), reflecting an explicit effort to extend the platform beyond academic systematic reviews into commercial life sciences and media verticals.

Short descriptiontext

Nested Knowledge provides a cloud-based evidence synthesis platform combining AutoLit® literature review workflow with Synthesis visualization tools, serving academic medical researchers, HEOR consultancies, medical device firms, and biopharma evidence teams.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaint Paul, United States
HQ citystring
Saint Paul
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
systematic review software, evidence synthesis platform, meta-analysis tools, literature review automation, medical research software
Industry1 code
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers5132
  • Web Search Portals, Libraries, Archives, and Other Information Services519
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Evidence Synthesis Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Platform Subscription
TypeFreemium
Description

Nested Knowledge operates on a freemium model where users can complete their first systematic review project for free with no time limits. The platform then likely offers paid subscription tiers for expanded usage, teams, and advanced features.

nested-knowledge.com
2Enterprise Onboarding Services
TypeProfessional Services
Description

The company offers tailored pilot project onboarding with complimentary research support for enterprise customers, suggesting professional services as a revenue component.

nested-knowledge.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Free tier for individual researchers
ModelFreemiumBilling cadenceMonthly
Notes

Complete an entire systematic review project for free, with no time limits. First review is free with no credit card required.

nested-knowledge.com
2Enterprise team plans
ModelSubscriptionBilling cadenceAnnual
Notes

Tailored pilot projects with complimentary research support for enterprise teams. Pricing available upon request.

nested-knowledge.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1AutoLit
Description

Evidence synthesis platform for literature search, screening, data extraction, and critical appraisal workflow.

nested-knowledge.com
+1 more record
Core offering1 text field

Nested Knowledge sells a two-part cloud SaaS platform that enables medical researchers and life sciences organizations to conduct systematic literature reviews and meta-analyses. AutoLit® handles search, AI-augmented screening, structured data extraction, and critical appraisal, while Synthesis powers qualitative synthesis, no-code quantitative meta-analysis, shareable dashboards, and living manuscript drafting. The platform is offered via freemium self-serve access for individuals and tailored enterprise pilot engagements for teams.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduces competitive intelligence preparation time from weeks to hours
+1 more record
Product overview1 text field

Nested Knowledge is a two-part platform composed of AutoLit® and Synthesis. AutoLit® provides the systematic review workflow (search, screening, data extraction, critical appraisal, and export), while Synthesis enables visualization, analysis, publication, and sharing of evidence derived from AutoLit data. Together, they enable medical researchers to accelerate, collaborate, automate, and share evidence synthesis for systematic reviews and meta-analyses.

Product and service1 record
1AutoLit®
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-26
Description

Strategic partnership to deliver AI-powered competitive intelligence services for life sciences organizations. Combines Prezent Vivo's AI + human expertise communication model with Nested Knowledge's AutoLit evidence synthesis platform. The integrated solution enables pharmaceutical and biotech teams to receive congress-ready competitive intelligence packages and monthly living evidence updates, reducing preparation time from weeks to hours. Partnership launched ahead of June congress season including ASCO, EHA, and ISTH.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-17
Description

Strategic collaboration to integrate AI-powered evidence synthesis into healthcare podcasting. Aims to improve credibility and accuracy of clinical education content. First episodes scheduled to launch in late January 2026.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-13
Description

Strategic partnership announced at ISPOR Europe 2025 to improve and accelerate the localization of Health Technology Assessment (HTA) dossiers globally. Combines AI-enabled evidence synthesis, expert-led translations, and rapid dossier adaptation to meet global regulatory needs. Enhances efficiency and compliance of HTA dossier localization for global health authorities.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1LitCovid
TypeOthers
Description

NLM-hosted curated literature hub for COVID-19 research. Adjacent as a literature-discovery resource in the same clinical-research evidence ecosystem, though not a commercial competitor.

TypeDirect peer
Description

Leading systematic review management platform used widely by Cochrane and academic researchers for screening, data extraction, and risk-of-bias assessment. Most directly comparable product offering to AutoLit's screening/extraction workflow.

TypeDirect peer
Description

Enterprise-grade systematic review and literature surveillance software used by regulatory, HTA, and medical device organizations. Targets the same biopharma/HEOR enterprise buyer as Nested Knowledge.

4Rayyan
TypeDirect peer
Description

AI-assisted systematic review screening platform widely used in academic research; comparable PLG motion (free tier + paid) and serves overlapping academic medical researcher segment.

5EPPI-Reviewer
TypeEmerging player
Description

Web-based systematic review software from UCL with strong academic adoption, including meta-analysis and machine-learning-assisted screening. Comparable in core systematic review functionality though more research-oriented than commercial.

TypeEmerging player
Description

Systematic review and evidence synthesis platform focused on clinical and public health research workflows. Comparable feature set with narrower commercial footprint.

TypeBroad incumbent
Description

Large incumbent providing scientific literature tools (EndNote), research intelligence (Cortellis), and life sciences data. Overlaps with Nested Knowledge's research-workflow and biopharma intelligence use cases as part of a much broader portfolio.

8Elsevier (Embase / Scopus)
TypeBroad incumbent
Description

Global publisher and data analytics incumbent owning Embase, Scopus, and other life sciences databases that Nested Knowledge integrates with. Strategic both as competitor and data source.

TypeEmerging player
Description

AI-powered clinical evidence search and synthesis platform for clinicians. Targets overlapping medical-research audience with a more consumer-facing AI question-answering experience.

10Mendel AI
TypeEmerging player
Description

Enterprise AI platform for life sciences focused on clinical and commercial evidence workflows, including medical affairs. Comparable in targeting biopharma evidence/medical-affairs buyers with AI-first positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nested Knowledge

Evidence Synthesis Softwarenested-knowledge.com

Nested Knowledge provides a cloud-based evidence synthesis platform combining AutoLit® literature review workflow with Synthesis visualization tools, serving academic medical researchers, HEOR consultancies, medical device firms, and biopharma evidence teams.

What Nested Knowledge does

Nested Knowledge, Inc. is a Delaware-incorporated, privately held software company founded in 2018 and headquartered in St. Paul, Minnesota. The company provides a two-part cloud-based evidence synthesis platform composed of AutoLit® — covering the systematic review workflow of literature search, AI-assisted screening, structured data extraction, and critical appraisal — and Synthesis, which delivers qualitative concept summarization, no-code quantitative meta-analysis, shareable dashboards, and living manuscript drafting with auto-updating tables and figures. The platform is designed to serve academic medical researchers, evidence synthesis consultancies, medical device and HEOR specialists, and increasingly biopharma and healthcare media organizations. The company is led by co-founder and CEO Kevin Kallmes, with Karl Holub as CTO and Keith Kallmes as President.

The business model combines a freemium self-serve layer with enterprise subscriptions and embedded professional services. Individual researchers can complete an entire systematic review project for free with no time limits and no credit card required, creating a product-led growth top-of-funnel; enterprise teams are onboarded through tailored pilot projects that include complimentary research support, with annual contract pricing available on request. The company's stated customer base includes HEOR and evidence synthesis firms (ECRI, ICER, FIECON, HEOR Ltd, NAMSA, OPEN Health, RTI Health Solutions, Medlior, Red Nucleus, Decisive Consulting, Indence Health, Marksman Healthcare, Mednavigate, Synex), medical device consultancies (Sterling Medical Devices, Superior Medical Experts, Zoll Medical), and academic institutions (Stanford Neurosurgery, Health Sciences Library), and the company claims to be trusted by thousands of researchers worldwide.

The company is venture-backed, having raised approximately $5.98 million cumulatively across disclosed rounds, including a $4.3 million exempt offering filed in January 2026 (with TCA Venture Group disclosed) and a prior $1.5 million round from Groove Capital in June 2021. Its go-to-market is supported by strategic partnerships announced in late 2025 and early 2026 with Prezent Vivo (biopharma competitive intelligence), Cliniphai (HTA dossier localization), and Pharmacy Podcast Network (healthcare podcasting), reflecting an explicit effort to extend the platform beyond academic systematic reviews into commercial life sciences and media verticals.

Nested Knowledge firmographics

Firmographics
Name
Nested Knowledge
Legal name
Nested Knowledge, Inc.
Website
https://nested-knowledge.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Nested Knowledge provides a cloud-based evidence synthesis platform combining AutoLit® literature review workflow with Synthesis visualization tools, serving academic medical researchers, HEOR consultancies, medical device firms, and biopharma evidence teams.
Ownership category
akta.pro rank

Nested Knowledge industry classification

Industry
Product category
Evidence Synthesis Software
NAICS
Software Publishers (5132), Web Search Portals, Libraries, Archives, and Other Information Services (519)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Systematic review software
  • Evidence synthesis platform
  • Meta-analysis tools
  • Literature review automation
  • Medical research software

Where Nested Knowledge is headquartered

Location

Headquarters

HQ city
Saint Paul
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Nested Knowledge business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Platform Subscription: Nested Knowledge operates on a freemium model where users can complete their first systematic review project for free with no time limits. The platform then likely offers paid subscription tiers for expanded usage, teams, and advanced features.
  2. Enterprise Onboarding Services: The company offers tailored pilot project onboarding with complimentary research support for enterprise customers, suggesting professional services as a revenue component.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree tier for individual researchers
SubscriptionAnnualEnterprise team plans

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Nested Knowledge product offering

Product offering

Core offering

Nested Knowledge sells a two-part cloud SaaS platform that enables medical researchers and life sciences organizations to conduct systematic literature reviews and meta-analyses. AutoLit® handles search, AI-augmented screening, structured data extraction, and critical appraisal, while Synthesis powers qualitative synthesis, no-code quantitative meta-analysis, shareable dashboards, and living manuscript drafting. The platform is offered via freemium self-serve access for individuals and tailored enterprise pilot engagements for teams.

Product overview

Nested Knowledge is a two-part platform composed of AutoLit® and Synthesis. AutoLit® provides the systematic review workflow (search, screening, data extraction, critical appraisal, and export), while Synthesis enables visualization, analysis, publication, and sharing of evidence derived from AutoLit data. Together, they enable medical researchers to accelerate, collaborate, automate, and share evidence synthesis for systematic reviews and meta-analyses.

Differentiator

Problem solved

Functional benefit

Brands

  • AutoLit: Evidence synthesis platform for literature search, screening, data extraction, and critical appraisal workflow.
  • Synthesis

Products and services

  • AutoLit®

Quantifiable outcome

  • Reduces competitive intelligence preparation time from weeks to hours
  • +1 more outcomes

Companies that use Nested Knowledge

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Nested Knowledge technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Nested Knowledge partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Prezent VivocoreStrategic or Co-development Partner · 26 May 2026Strategic partnership to deliver AI-powered competitive intelligence services for life sciences organizations. Combines Prezent Vivo's AI + human expertise communication model with Nested Knowledge's AutoLit evidence synthesis platform. The integrated solution enables pharmaceutical and biotech teams to receive congress-ready competitive intelligence packages and monthly living evidence updates, reducing preparation time from weeks to hours. Partnership launched ahead of June congress season including ASCO, EHA, and ISTH.
  • Pharmacy Podcast NetworkminorStrategic or Co-development Partner · 17 December 2025Strategic collaboration to integrate AI-powered evidence synthesis into healthcare podcasting. Aims to improve credibility and accuracy of clinical education content. First episodes scheduled to launch in late January 2026.
  • CliniphaicoreStrategic or Co-development Partner · 13 November 2025Strategic partnership announced at ISPOR Europe 2025 to improve and accelerate the localization of Health Technology Assessment (HTA) dossiers globally. Combines AI-enabled evidence synthesis, expert-led translations, and rapid dossier adaptation to meet global regulatory needs. Enhances efficiency and compliance of HTA dossier localization for global health authorities.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Nested Knowledge competitors and assessment

Company assessment

Others

  • LitCovid: NLM-hosted curated literature hub for COVID-19 research. Adjacent as a literature-discovery resource in the same clinical-research evidence ecosystem, though not a commercial competitor.

Direct peers

  • Covidence: Leading systematic review management platform used widely by Cochrane and academic researchers for screening, data extraction, and risk-of-bias assessment. Most directly comparable product offering to AutoLit's screening/extraction workflow.
  • DistillerSR (Evidence Partners): Enterprise-grade systematic review and literature surveillance software used by regulatory, HTA, and medical device organizations. Targets the same biopharma/HEOR enterprise buyer as Nested Knowledge.
  • Rayyan: AI-assisted systematic review screening platform widely used in academic research; comparable PLG motion (free tier + paid) and serves overlapping academic medical researcher segment.

Emerging players

  • EPPI-Reviewer: Web-based systematic review software from UCL with strong academic adoption, including meta-analysis and machine-learning-assisted screening. Comparable in core systematic review functionality though more research-oriented than commercial.
  • PICO Portal: Systematic review and evidence synthesis platform focused on clinical and public health research workflows. Comparable feature set with narrower commercial footprint.
  • OpenEvidence: AI-powered clinical evidence search and synthesis platform for clinicians. Targets overlapping medical-research audience with a more consumer-facing AI question-answering experience.
  • Mendel AI: Enterprise AI platform for life sciences focused on clinical and commercial evidence workflows, including medical affairs. Comparable in targeting biopharma evidence/medical-affairs buyers with AI-first positioning.

Broad incumbents

  • Clarivate (EndNote / Cortellis): Large incumbent providing scientific literature tools (EndNote), research intelligence (Cortellis), and life sciences data. Overlaps with Nested Knowledge's research-workflow and biopharma intelligence use cases as part of a much broader portfolio.
  • Elsevier (Embase / Scopus): Global publisher and data analytics incumbent owning Embase, Scopus, and other life sciences databases that Nested Knowledge integrates with. Strategic both as competitor and data source.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Nested Knowledge social profiles

Digital presence

Nested Knowledge financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nested Knowledge leadership team

Management profile

Number of profiles

Profiles3 records

Nested Knowledge funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nested Knowledge M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nested Knowledge

What does Nested Knowledge do?

Nested Knowledge sells a two-part cloud SaaS platform that enables medical researchers and life sciences organizations to conduct systematic literature reviews and meta-analyses. AutoLit® handles search, AI-augmented screening, structured data extraction, and critical appraisal, while Synthesis powers qualitative synthesis, no-code quantitative meta-analysis, shareable dashboards, and living manuscript drafting. The platform is offered via freemium self-serve access for individuals and tailored enterprise pilot engagements for teams.

Is Nested Knowledge a public or private company?

Nested Knowledge is a private company. It is classified as venture growth investor backed and is currently operating.

When was Nested Knowledge founded?

Nested Knowledge was founded in 2018. It employs 11 to 50 people.

Where is Nested Knowledge based?

Nested Knowledge is headquartered in Saint Paul, United States, in the North America region.

How does Nested Knowledge make money?

Two revenue lines are on record. Platform Subscription is the primary driver. The others are enterprise Onboarding Services.

Who are Nested Knowledge's main competitors?

LitCovid is listed as an others. Direct peers are Covidence, DistillerSR (Evidence Partners) and Rayyan. Emerging players are EPPI-Reviewer, PICO Portal, OpenEvidence and Mendel AI. Broad incumbents are Clarivate (EndNote / Cortellis) and Elsevier (Embase / Scopus).

Does Nested Knowledge have an API?

No public API is recorded for Nested Knowledge.

What industry is Nested Knowledge in?

Nested Knowledge's product category is Evidence Synthesis Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
techindc.comThe future of life sciences communication starts with Prezent – techindc.comPrezent has established itself as a leading communications platform for the life sciences sector, combining AI technology with human expertise to help biopharma companies translate complex clinical data into compelling narratives for various audiences. The platform, which claims to serve 45 of the top 50 largest biopharma companies, has expanded its capabilities through a partnership with Nested Knowledge to integrate AI-powered competitive intelligence directly into its workflow. The life sciences industry is projected to grow to nearly $278 billion by 2034, driven by AI breakthroughs and high-value acquisitions.TechliPrezent becomes the communications partner of choice for life sciencesPrezent positions itself as a communications partner for life sciences, serving 45 of the top 50 biopharma companies. The U.S. life sciences sector is projected to reach $278 billion by 2034, and Prezent's AI and human expert platform aims to accelerate clinical research and product launches.TechliPrezent Vivo and Nested Knowledge team up to reinvent competitive intelligence for life sciencesPrezent Vivo and Nested Knowledge announced a partnership combining AI-powered evidence synthesis with scientific communications for life sciences. The collaboration integrates Nested Knowledge's AutoLit engine, which reduces systematic review timelines by over 70%, with Prezent Vivo's AI-plus-human model to deliver congress-ready intelligence. Services include pre-congress briefings and post-presentation synthesis packages.PR NewswirePrezent Vivo and Nested Knowledge Partner to Bring AI-Powered Competitive Intelligence to Life Sciences TeamsPrezent Vivo and Nested Knowledge announced a strategic partnership to deliver AI-powered competitive intelligence services for life sciences organizations, combining Prezent Vivo's AI + human expertise communication model with Nested Knowledge's AutoLit evidence synthesis platform. The integrated solution enables pharmaceutical and biotech teams to receive congress-ready competitive intelligence packages and monthly living evidence updates, reducing preparation time from weeks to hours. The partnership launches ahead of the June congress season, including major medical meetings such as ASCO, EHA, and ISTH.SecSEC FORM DNested Knowledge, Inc., a Delaware-incorporated technology company based in St. Paul, Minnesota, filed a Form D notice with the SEC for an exempt offering of securities under Rule 506(b). The offering, which includes equity securities such as preferred stock and convertible capital stock, has a total offering amount of approximately $4.3 million, with $4.18 million already sold to 39 investors and $135,000 remaining.PharmiWeb.comNested Knowledge and Pharmacy Podcast Network Announce Strategic Collaboration to Advance Evidence-Based Podcasting in HealthcareThe Pharmacy Podcast Network (PPN) and Nested Knowledge announced a strategic collaboration on December 17, 2025, to advance evidence-based podcasting in healthcare by integrating AI-powered evidence synthesis into PPN's pharmacist-led audio programming. Through this partnership, PPN will use Nested Knowledge's technology to collect, organize, and validate clinical evidence supporting its therapeutic discussions, policy developments, and emerging innovations. The first series of evidence-enhanced podcast episodes is scheduled to launch the week of January 26, 2026, positioning the collaboration to address growing demand for credible, audio-first healthcare education.BioSpaceCliniphai and Nested Knowledge Announce Partnership at ISPOR Europe 2025 to Accelerate Global Health Technology Assessment (HTA) Dossier Localization with AICliniphai and Nested Knowledge announced a strategic partnership at ISPOR Europe 2025 to accelerate the localization of Health Technology Assessment (HTA) dossiers using AI and human-in-the-loop translation technology. The collaboration aims to reduce time and improve accuracy in translating clinical evidence for global regulatory compliance.GlobeNewswireCytel Partners with Nested Knowledge to Power the Next Generation of AI-Enhanced LiveSLR® for HEOR and HTACytel announced a partnership with Nested Knowledge to power its LiveSLR software with AI-powered systematic literature review technology. The collaboration creates an auditable living evidence platform for Health Economics and Outcomes Research and Health Technology Assessment, combining Cytel's methodology with Nested Knowledge's AI automation.GlobeNewswireCytel Partners with Nested Knowledge to Power the Next Generation of AI-Enhanced LiveSLR® for HEOR and HTACytel announced a partnership with Nested Knowledge to integrate AI-powered systematic literature review technology into its LiveSLR platform for HEOR and HTA. The collaboration combines Cytel's expert-led search strategies and database access with Nested Knowledge's AI-driven automation. The partnership aims to provide auditable, real-time evidence for health economics and reimbursement decisions.PR NewswireRTI International and Nested Knowledge Announce Collaboration to Enhance Life Science and Healthcare ResearchRTI International and Nested Knowledge announced a strategic collaboration and equity investment, combining RTI Health Solutions' research expertise with Nested Knowledge's AI-driven evidence synthesis platform and Gen-AI tools for systematic literature reviews. The collaboration will provide clients with enhanced analytical and technical capabilities for clinical inquiries and evidence generation. Both organizations emphasized responsible use of Gen-AI and expressed confidence that the partnership will advance the field of evidence synthesis.